63 related articles for article (PubMed ID: 25575524)
21. An E3 ubiquitin ligase: c-Cbl: a new therapeutic target of lung cancer.
Lo FY; Tan YH; Cheng HC; Salgia R; Wang YC
Cancer; 2011 Dec; 117(23):5344-50. PubMed ID: 21607942
[TBL] [Abstract][Full Text] [Related]
22. Discrete protein interactions with the Grb2/c-Cbl complex in SCF- and TPO-mediated myeloid cell proliferation.
Brizzi MF; Dentelli P; Lanfrancone L; Rosso A; Pelicci PG; Pegoraro L
Oncogene; 1996 Nov; 13(10):2067-76. PubMed ID: 8950973
[TBL] [Abstract][Full Text] [Related]
23. Cbl E3 Ligase Mediates the Removal of Nectin-1 from the Surface of Herpes Simplex Virus 1-Infected Cells.
Deschamps T; Dogrammatzis C; Mullick R; Kalamvoki M
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381567
[TBL] [Abstract][Full Text] [Related]
24. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
25. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
26. Cbl-dependent ubiquitination is required for progression of EGF receptors into clathrin-coated pits.
Stang E; Blystad FD; Kazazic M; Bertelsen V; Brodahl T; Raiborg C; Stenmark H; Madshus IH
Mol Biol Cell; 2004 Aug; 15(8):3591-604. PubMed ID: 15194809
[TBL] [Abstract][Full Text] [Related]
27. CBL-GRB2 interaction in myeloid immunoreceptor tyrosine activation motif signaling.
Park RK; Kyono WT; Liu Y; Durden DL
J Immunol; 1998 May; 160(10):5018-27. PubMed ID: 9590251
[TBL] [Abstract][Full Text] [Related]
28. Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody.
Lee JM; Kim B; Lee SB; Jeong Y; Oh YM; Song YJ; Jung S; Choi J; Lee S; Cheong KH; Kim DU; Park HW; Han YK; Kim GW; Choi H; Song PH; Kim KA
Oncogene; 2014 Jan; 33(1):34-43. PubMed ID: 23208509
[TBL] [Abstract][Full Text] [Related]
29. CSF-1 stimulation induces the formation of a multiprotein complex including CSF-1 receptor, c-Cbl, PI 3-kinase, Crk-II and Grb2.
Husson H; Mograbi B; Schmid-Antomarchi H; Fischer S; Rossi B
Oncogene; 1997 May; 14(19):2331-8. PubMed ID: 9178909
[TBL] [Abstract][Full Text] [Related]
30. Intersectin regulates epidermal growth factor receptor endocytosis, ubiquitylation, and signaling.
Martin NP; Mohney RP; Dunn S; Das M; Scappini E; O'Bryan JP
Mol Pharmacol; 2006 Nov; 70(5):1643-53. PubMed ID: 16914641
[TBL] [Abstract][Full Text] [Related]
31. c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.
Penengo L; Rubin C; Yarden Y; Gaudino G
Oncogene; 2003 Jun; 22(24):3669-79. PubMed ID: 12802274
[TBL] [Abstract][Full Text] [Related]
32. The Cbl family proteins: ring leaders in regulation of cell signaling.
Swaminathan G; Tsygankov AY
J Cell Physiol; 2006 Oct; 209(1):21-43. PubMed ID: 16741904
[TBL] [Abstract][Full Text] [Related]
33. Grb2 mediates negative regulation of stem cell factor receptor/c-Kit signaling by recruitment of Cbl.
Sun J; Pedersen M; Bengtsson S; Rönnstrand L
Exp Cell Res; 2007 Nov; 313(18):3935-42. PubMed ID: 17904548
[TBL] [Abstract][Full Text] [Related]
34. The E3 ubiquitin ligase Cbl-b improves the prognosis of RANK positive breast cancer patients by inhibiting RANKL-induced cell migration and metastasis.
Zhang L; Teng Y; Fan Y; Wang Y; Li W; Shi J; Ma Y; Li C; Shi X; Qu X; Liu Y
Oncotarget; 2015 Sep; 6(26):22918-33. PubMed ID: 26087197
[TBL] [Abstract][Full Text] [Related]
35. The chimeric ubiquitin ligase SH2-U-box inhibits the growth of imatinib-sensitive and resistant CML by targeting the native and T315I-mutant BCR-ABL.
Ru Y; Wang Q; Liu X; Zhang M; Zhong D; Ye M; Li Y; Han H; Yao L; Li X
Sci Rep; 2016 Jun; 6():28352. PubMed ID: 27329306
[TBL] [Abstract][Full Text] [Related]
36. High affinity IgG receptor activation of Src family kinases is required for modulation of the Shc-Grb2-Sos complex and the downstream activation of the nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Park RK; Erdreich-Epstein A; Liu M; Izadi KD; Durden DL
J Immunol; 1999 Dec; 163(11):6023-34. PubMed ID: 10570290
[TBL] [Abstract][Full Text] [Related]
37. Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.
Timpson P; Lynch DK; Schramek D; Walker F; Daly RJ
Cancer Res; 2005 Apr; 65(8):3273-80. PubMed ID: 15833860
[TBL] [Abstract][Full Text] [Related]
38. Regulator of epidermal growth factor signaling: Sprouty.
Wong ES; Guy GR
Methods Mol Biol; 2006; 327():61-83. PubMed ID: 16780213
[TBL] [Abstract][Full Text] [Related]
39. E3 ubiquitin ligases Cbl-b and c-Cbl downregulate PD-L1 in EGFR wild-type non-small cell lung cancer.
Wang S; Xu L; Che X; Li C; Xu L; Hou K; Fan Y; Wen T; Qu X; Liu Y
FEBS Lett; 2018 Feb; 592(4):621-630. PubMed ID: 29364514
[TBL] [Abstract][Full Text] [Related]
40. EGFRvIII escapes down-regulation due to impaired internalization and sorting to lysosomes.
Grandal MV; Zandi R; Pedersen MW; Willumsen BM; van Deurs B; Poulsen HS
Carcinogenesis; 2007 Jul; 28(7):1408-17. PubMed ID: 17372273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
